Filtros de búsqueda

Lista de obras de Krzysztof Selmaj

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

artículo científico publicado en 2010

ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS

artículo científico publicado en 2016

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

artículo científico publicado en 2016

Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

artículo científico publicado en 2011

Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis

artículo científico publicado en 2009

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination ⬇️

artículo científico publicado el 1 de noviembre de 1991

Bickerstaff's brainstem encephalitis -- an analysis of clinical and MRI findings

artículo científico publicado en 2006

Blood serotonin level in sciatica and the serotonin theory of migraine pathogenesis

artículo científico publicado el 1 de marzo de 1979

Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.

artículo científico publicado en 2014

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS

artículo científico publicado en 2015

Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS: Patient management considerations

artículo científico publicado en 2016

Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis

scientific article published on 25 May 2019

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

artículo científico publicado en 2015

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

artículo científico publicado en 2013

Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.

artículo científico publicado en 2008

Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis ⬇️

artículo científico publicado el 1 de agosto de 1991

Corpora amylacea from multiple sclerosis brain tissue consists of aggregated neuronal cells.

artículo científico publicado en 2008

DACLIZUMAB HYP IN MULTIPLE SCLEROSIS: 3-YEAR RESULTS FROM SELECTED

artículo científico publicado en 2016

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

artículo científico publicado en 2015

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2013

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

artículo científico publicado en 2014

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2016

Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination

artículo científico publicado en 2004

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

artículo científico publicado en 2020

Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activity

artículo científico publicado en 2011

Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination.

artículo científico publicado en 2015

EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity

scientific article published on 01 October 2007

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

artículo científico publicado en 2018

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

artículo científico publicado en 2018

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

artículo científico publicado en 2014

Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study

artículo científico publicado en 2016

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study

scientific article published on 25 July 2018

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE.

artículo científico publicado en 2017

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

artículo científico publicado en 2014

Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial

artículo científico

Experimental autoimmune encephalomyelitis: CC chemokine receptor expression by trafficking cells

artículo científico publicado en 2002

Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: implications for multiple sclerosis

artículo científico publicado el 1 de abril de 1992

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

artículo científico publicado en 2020

Follow-on glatiramer acetate

artículo científico publicado en 2018

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

HINT1 peptide/Hsp70 complex induces NK-cell-dependent immunoregulation in a model of autoimmune demyelination.

artículo científico publicado en 2014

Heat shock protein 70 (Hsp70) interacts with the Notch1 intracellular domain and contributes to the activity of Notch signaling in myelin-reactive CD4 T cells

artículo científico publicado en 2015

High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS

artículo científico publicado en 2014

Hyperintense basal ganglia on T1-weighted magnetic resonance images in a patient with common variable immunodeficiency associated with elevated serum manganese

scientific article published on 01 January 2002

Hypoglycemia as a trigger for the syndrome of acute bilateral basal ganglia lesions in uremia

artículo científico publicado en 2010

Immune regulation of multiple sclerosis by transdermally applied myelin peptides

scientific article published on 01 November 2010

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management

scientific article published on 20 February 2019

Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2

artículo científico publicado en 2011

Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials

artículo científico publicado en 2019

Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis

artículo científico publicado en 2006

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

artículo científico publicado en 2010

Incidence of migraine among physicians of the city of Lódź and their families

artículo científico publicado el 1 de enero de 1980

Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10.

artículo científico publicado en 2015

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study

artículo científico publicado en 2018

Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis.

artículo científico publicado en 2005

Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland

artículo científico publicado en 2014

Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis

artículo científico publicado en 2007

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans

artículo científico publicado en 2006

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

artículo científico publicado en 2015

Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study

scientific article published on 25 May 2020

Lymphotoxin production in multiple sclerosis patients

artículo científico publicado el 1 de enero de 1991

MANAGEMENT OF ADVERSE REACTIONS TO ALEMTUZUMAB INFUSION

artículo científico publicado en 2015

MTR discloses subtle changes in the normal-appearing tissue from relatives of patients with MS

artículo científico publicado en 2002

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

artículo científico publicado en 2014

MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2.

artículo científico publicado en 2013

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

artículo científico publicado en 2005

Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland

article

Multiple sclerosis: Presence of serum antibodies to lipids and predominance of cholesterol recognition.

artículo científico publicado en 2017

Multiple sclerosis: Skin-induced antigen-specific immune tolerance

artículo científico publicado en 2017

Natalizumab and the development of extensive brain lesions in neuromyelitis optica

artículo científico publicado en 2013

New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland.

artículo científico publicado en 2017

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

artículo científico publicado en 2018

Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis

artículo científico publicado en 2008

Notch: a new player in MS mechanisms

artículo científico publicado en 2009

Novel emerging treatments for NMOSD

scientific article published on 01 January 2019

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

artículo científico publicado en 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

artículo científico publicado en 2016

Ofatumumab versus Teriflunomide in Multiple Sclerosis

artículo científico publicado en 2020

Open trial of the effectiveness of interferon beta 1a (Avonex) in multiple sclerosis. Clinical assessment using motor coordination tests

artículo científico publicado en 2003

Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy

artículo científico publicado en 2008

Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of Notch signaling

scientific article published on 18 October 2007

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.

artículo científico publicado en 2008

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

artículo científico publicado en 2012

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program

scientific article published on 13 July 2016

Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit

scientific article published on 01 December 1989

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study

artículo científico publicado en 2013

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

artículo científico publicado en 2015

Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis

scientific article published on 21 October 2020

Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis

artículo científico publicado en 2020

Relapse of neuromyelitis optica during pregnancy--treatment options and literature review.

artículo científico publicado en 2015

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

artículo científico

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.

artículo científico publicado en 2016

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

artículo científico publicado en 2016

Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.

artículo científico publicado en 2008

Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study

artículo científico publicado en 2014

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

artículo científico publicado en 2013

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis.

artículo científico publicado en 2009

Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis

scientific article published on 01 January 2007

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

artículo científico publicado en 2015

Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism

scientific article published on January 2008

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

artículo científico publicado en 2007

Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results

artículo científico publicado en 2017

TNF-alpha microinjection upregulates chemokines and chemokine receptors in the central nervous system without inducing leukocyte infiltration

artículo científico publicado en 2003

TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3.

artículo científico publicado en 2003

TRAIL induces death of human oligodendrocytes isolated from adult brain

artículo científico publicado en 2002

TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway.

artículo científico publicado en 2006

The Heat Shock Protein HSP70 Promotes Th17 Genes' Expression via Specific Regulation of microRNA

scientific article published on 17 April 2020

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis

artículo científico publicado en 2013

Thyroid hormones influence human dendritic cells' phenotype, function, and subsets distribution

scientific article published on 29 December 2010

Transdermal application of myelin peptides in multiple sclerosis treatment

artículo científico publicado en 2013

Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression

artículo científico publicado en 2004

Tumor Necrosis Factor-Induced Proliferation of Astrocytes from Mature Brain Is Associated with Down-Regulation of Glial Fibrillary Acidic Protein mRNA ⬇️

artículo científico publicado el 1 de septiembre de 1991

Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.

artículo científico publicado en 2005

[Antemortem diagnosis of Balo's concentric sclerosis based on MRI. Case report]

artículo científico publicado en 2002

[Cognitive impairment in multiple sclerosis]

scientific article published on 01 March 2005

[Familial congenital bilateral Duane's retraction syndrome (Stilling-Turk-Duane syndrome). A case report]

artículo científico publicado en 2003

[Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases]

artículo científico publicado en 2002

[Open trial of the effectiveness of interferon beta 1a (Avonex) in the treatment of multiple sclerosis in Poland: MRI results]

artículo científico publicado en 2003

miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda